| FGFR a promising druggable target in cancer: Molecular biology and new drugs R Porta, R Borea, A Coelho, S Khan, A Araújo, P Reclusa, T Franchina, ... Critical reviews in oncology/hematology 113, 256-267, 2017 | 256 | 2017 |
| Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer U Malapelle, R Sirera, E Jantus-Lewintre, P Reclusa, S Calabuig-Fariñas, ... Expert review of molecular diagnostics 17 (3), 209-215, 2017 | 190 | 2017 |
| Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathway S Taverna, M Pucci, M Giallombardo, MA Di Bella, M Santarpia, ... Scientific reports 7 (1), 3170, 2017 | 156 | 2017 |
| Exosomes as diagnostic and predictive biomarkers in lung cancer P Reclusa, S Taverna, M Pucci, E Durendez, S Calabuig, P Manca, ... Journal of thoracic disease 9 (Suppl 13), S1373, 2017 | 125 | 2017 |
| Circulating cell-free DNA and RNA analysis as liquid biopsy: optimal centrifugation protocol L Sorber, K Zwaenepoel, J Jacobs, K De Winne, S Goethals, P Reclusa, ... Cancers 11 (4), 458, 2019 | 96 | 2019 |
| Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer A Valentino, P Reclusa, R Sirera, M Giallombardo, C Camps, P Pauwels, ... Clinical and translational oncology 19, 651-657, 2017 | 93 | 2017 |
| Exosomes genetic cargo in lung cancer: a truly Pandora’s box P Reclusa, R Sirera, A Araujo, M Giallombardo, A Valentino, L Sorber, ... Translational lung cancer research 5 (5), 483, 2016 | 46 | 2016 |
| Improving extracellular vesicles visualization: From static to motion P Reclusa, P Verstraelen, S Taverna, M Gunasekaran, M Pucci, I Pintelon, ... Scientific reports 10 (1), 6494, 2020 | 43 | 2020 |
| Extracellular vesicles as miRNA nano-shuttles: dual role in tumor progression M Pucci, P Reclusa Asiáin, E Duréndez Sáez, E Jantus-Lewintre, ... Targeted oncology 13, 175-187, 2018 | 34 | 2018 |
| EML4-ALK translocation identification in RNA exosomal cargo (ExoALK) in NSCLC patients: a novel role for liquid biopsy P Reclusa, JF Laes, U Malapelle, A Valentino, D Rocco, I Gil-Bazo, ... Translational Cancer Research 8 (Suppl 1), S76, 2019 | 30 | 2019 |
| Follow up analysis by exosomal miRNAs in EGFR mutated non-small cell lung cancer (NSCLC) patients during osimertinib (AZD9291) treatment: A potential prognostic biomarker tool. M Giallombardo, J Jorge Chacartegui, P Reclusa, JP Van Meerbeeck, ... Journal of Clinical Oncology 34 (15_suppl), e23035-e23035, 2016 | 18 | 2016 |
| Exosomes in lung cancer liquid biopsies: Two sides of the same coin? C Rolfo, M Giallombardo, P Reclusa, R Sirera, M Peeters Lung Cancer 104, 134-135, 2017 | 13 | 2017 |
| Exosomes in semen: opportunities as a new tool in prostate cancer diagnosis M Pucci, S Taverna, P Reclusa, JA Pinto, E Durendez, EJ Lewintre, ... Translational Cancer Research 6 (Suppl 8), 2017 | 12 | 2017 |
| P2. 01-093 Exo-ALK proof of concept: exosomal analysis of ALK alterations in advanced NSCLC patients: topic: targets for treatment prediction C Rolfo, JF Laes, P Reclusa, A Valentino, M Lienard, I Gil-Bazo, ... Journal of Thoracic Oncology 12 (1), S844-S845, 2017 | 8 | 2017 |
| Liquid biopsy in non-small cell lung cancer (NSCLC) C Rolfo, M Castiglia, A Perez, P Reclusa, P Pauwels, L Sober, F Passiglia, ... Liquid Biopsy in Cancer Patients: The Hand Lens for Tumor Evolution, 103-115, 2017 | 5 | 2017 |
| P2. 06: Exosomal miRNA analysis in non-small cell lung cancer: New liquid biomarker?: Track: Biology and pathogenesis P Reclusa, M Giallombardo, M Castiglia, L Sorber, N Van Der Steen, ... Journal of Thoracic Oncology 11 (10), S219-S220, 2016 | 5 | 2016 |
| Liquid biopsy analysis of ALK alterations from advanced NSCLC patients: The value of exosomal RNA cargo (ExoALK). CD Rolfo, JF Laes, P Reclusa, M Lienard, I Gil-Bazo, U Malapelle, ... Journal of Clinical Oncology 35 (15_suppl), e20569-e20569, 2017 | 4 | 2017 |
| Circulating micrornas and long noncoding rnas: liquid biomarkers in thoracic cancers P Reclusa, A Valentino, R Sirera, M Dietrich, L Raez, C Rolfo Cancer Translational Medicine 3 (2), 2017 | 3 | 2017 |
| P2. 09: cMET in NSCLC: Expression, amplification and mutations: track: biology and pathogenesis N Van Der Steen, C Rolfo, E Giovannetti, P Reclusa, GJ Peters, ... Journal of Thoracic Oncology 11 (10), S221-S222, 2016 | 2 | 2016 |
| P2. 07: Evaluation of different exosomal RNA isolation methods in nsclc liquid biopsies: Track: Biology and pathogenesis M Giallombardo, P Reclusa, A Valentino, R Sirera, P Pauwels, C Rolfo Journal of Thoracic Oncology 11 (10), S220-S221, 2016 | 1 | 2016 |
